SEC Filings | BioLineRx

Filing Date	Form	Description	View
Aug 08, 2013	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	0001178913-13-002349.rtf 0001178913-13-002349.xls 0001178913-13-002349.pdf
Aug 08, 2013	EFFECT	EFFECT	9999999995-13-002347.rtf 9999999995-13-002347.xls 9999999995-13-002347.pdf
Aug 06, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-002280.rtf 0001178913-13-002280.xls 0001178913-13-002280.pdf
Aug 05, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-002256.rtf 0001178913-13-002256.xls 0001178913-13-002256.pdf
Jul 29, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-002176.rtf 0001178913-13-002176.xls 0001178913-13-002176.pdf
Jul 26, 2013	POS AM	Post-effective amendment to an S-Type filing	0001178913-13-002162.rtf 0001178913-13-002162.xls 0001178913-13-002162.pdf
Jul 11, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-002044.rtf 0001178913-13-002044.xls 0001178913-13-002044.pdf
Jul 10, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-002035.rtf 0001178913-13-002035.xls 0001178913-13-002035.pdf
Jun 10, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-001748.rtf 0001178913-13-001748.pdf
Jun 06, 2013	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-13-001738.rtf 0001178913-13-001738.xls 0001178913-13-001738.pdf

Data provided by Kaleidoscope.